Mater Medical Research Institute
10 Jan
Mater Medical Research Institute (MMRI) was established in 1998 originally with a concentration on fundamental scientific research into cancer with a focus on cancer biotherapy.
QUT IHBI
4 Oct
QUT Institute of Health and Biomedical Innovation (IHBI) opened its facility in 2006 with a vision to help communities with a collaboration of expertise in health, science, technology and built environment and engineering.
PRINCESS ALEXANDRA
10 Jan
The Princess Alexandra Hospital Centres for Health Research was established to foster research on and in collaboration with the campus across the whole spectrum of research from basic biomedical to translational, clinical, health services and population health research.
UNIVERSITY OF QLD
10 Jan
The University of Queensland's Diamantina Institute was established by 2006 Australian of the Year, UQ's own Professor Ian Frazer in 2007.
Building to start on $354 million Brisbane research centre
10 Jan
Watpac Construction was today named as the successful tender for the contract to build the $354 million Translational Research Institute (TRI) in Brisbane.
hero01 hero02a hero03 hero04 hero05

The Translational Research Institute

TRI will bring four of the country’s pinnacle research facilities together with the aim of improving and accelerating medical research and translating that research into greater patient care. The TRI will allow – for the first time in Australia – biopharmaceuticals and treatments to be discovered, produced, clinically tested and manufactured in one location.

The TRI will focus on a wide range of health and medical research areas including cervical cancer, breast cancer, melanoma, liver and kidney disease, malaria, HIV, osteoporosis, obesity, arthritis and diabetes.

The TRI is a joint venture between The University of Queensland Diamantina Institute, Queensland University of Technology’s Institute of Health and Biomedical Innovation, Mater Medical Research Institute and the Princess Alexandra Hospital’s Centres for Health Research. The TRI has been made possible through $354 million in funding which was provided by the Australian and Queensland Governments, The Atlantic Philanthropies, UQ and QUT.

The centre was the vision of 2006 Australian of the Year Professor Ian Frazer – inventor of the cervical cancer vaccine (HPV) – and the Mater Medical Research Institute.